ChlVPP-EVA regimen: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{AV}} | {{CMG}}; {{AE}} {{AV}} | ||
{{SK}} Etoposide-Vincristine-Adriamycin-Chlorambucil-Vinblastine-Procarbazine-Prednisone | {{SK}} EVA-ChlVPP Regimen; Etoposide-Vincristine-Adriamycin-Chlorambucil-Vinblastine-Procarbazine-Prednisone Regimen | ||
==Overview== | ==Overview== | ||
{{PAGENAME}} refers to a regimen derived from the original MOPP-ABVD regimen, consisting of [[ | {{PAGENAME}} refers to a regimen derived from the original MOPP-ABVD regimen, consisting of [[chlorambucil]], [[vinblastine]], [[procarbazine]], [[prednisone]] and [[etoposide]],[[vincristine]], [[doxorubicin|doxorubicin (Adriamycin)]] used for the initial treatment of [[Hodgkin's lymphoma]].<ref>{{Cite web | title = NCI Thesaurus | accessdate = | url = http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C63452 }}</ref><ref>{{Cite web | title = R-CHOP - National Cancer Institute | accessdate = | url = http://www.cancer.gov/cancertopics/druginfo/R-CHOP }}</ref> | ||
==Regimen== | ==Regimen== | ||
{{chemo|Chl|Chlorambucil}} | |||
{{chemo|V|Vincristine (Oncovin)}} | |||
{{chemo|P|Procarbazine}} | |||
{{chemo|P|Prednisone}} | |||
{{chemo|E|Etoposide}} | |||
{{chemo|V|Vinblastine}} | |||
{{chemo|A|Doxorubicin (Adriamycin)}} | |||
==Indications== | ==Indications== | ||
* [[Hodgkin's lymphoma]]<ref name="pmid21726488">{{cite journal| author=Rahemtulla A, Terpos E| title=Hodgkin's lymphoma. | journal=BMJ Clin Evid | year= 2009 | volume= 2009 | issue= | pages= | pmid=21726488 | doi= | pmc=PMC2907766 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21726488 }} </ref> | * [[Hodgkin's lymphoma]]<ref name="pmid21726488">{{cite journal| author=Rahemtulla A, Terpos E| title=Hodgkin's lymphoma. | journal=BMJ Clin Evid | year= 2009 | volume= 2009 | issue= | pages= | pmid=21726488 | doi= | pmc=PMC2907766 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21726488 }} </ref> |
Latest revision as of 15:09, 11 March 2015
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords: EVA-ChlVPP Regimen; Etoposide-Vincristine-Adriamycin-Chlorambucil-Vinblastine-Procarbazine-Prednisone Regimen
Overview
ChlVPP-EVA regimen refers to a regimen derived from the original MOPP-ABVD regimen, consisting of chlorambucil, vinblastine, procarbazine, prednisone and etoposide,vincristine, doxorubicin (Adriamycin) used for the initial treatment of Hodgkin's lymphoma.[1][2]
Regimen
ChlChlorambucil
VVincristine (Oncovin)
PProcarbazine
PPrednisone
EEtoposide
VVinblastine
ADoxorubicin (Adriamycin)
Indications
References
- ↑ "NCI Thesaurus".
- ↑ "R-CHOP - National Cancer Institute".
- ↑ Rahemtulla A, Terpos E (2009). "Hodgkin's lymphoma". BMJ Clin Evid. 2009. PMC 2907766. PMID 21726488.